National drug policies to local formulary decisions in Thailand, China, and Australia: drug listing changes and opportunities

Value Health. 2012 Jan-Feb;15(1 Suppl):S126-31. doi: 10.1016/j.jval.2011.11.003.

Authors

Worasuda Yoongthong¹, Shanlian Hu, Jennifer A Whitty, Suwit Wibulpolprasert, Kitti Sukantho, Wannisa Thienthawee, Huixue Han, Paul A Scuffham

Affiliation

¹ Bureau of Drug, Food and Drug Administration, Ministry of Public Health, Nonthaburi, Thailand. worasuda@fda.moph.go.th

PMID: 22265059
DOI: 10.1016/j.jval.2011.11.003

No abstract available

MeSH terms

Australia
China
Decision Making*
Drug Utilization
Formularies as Topic*
Health Policy*
Health Services Accessibility / organization & administration
Humans
Insurance, Health, Reimbursement / economics*
National Health Programs / economics
National Health Programs / organization & administration*
Quality of Health Care / organization & administration
Thailand